Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 10 - 26 tags : Presentation save search
Rain Therapeutics Announces a Poster Presentation at the 34th EORTC/AACR/NCI Symposium
Published: 2022-10-26 (Crawled : 19:00) - globenewswire.com
RAIN | $1.21 0.0% 3.7M
|
Manufacturing
|
| O: 5.5%
H: 5.04%
C: -2.52%
symposium therapeutics presentation
Galera Announces Presentation of Phase 3 ROMAN Long-term Follow-up Data at 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting
Published: 2022-10-26 (Crawled : 18:00) - globenewswire.com
GRTX | $0.1821 -6.13% -6.53% 810K
|
Health Technology
|
| O: -1.69%
H: 5.71%
C: -4.0%
meeting presentation
Aldeyra Therapeutics Announces Oral Presentation of Phase 3 Data at the American Academy of Optometry 2022 Annual Meeting
Published: 2022-10-26 (Crawled : 13:20) - biospace.com/
ALDX | $3.93 0.51% 0.51% 570K
|
Health Technology
|
| O: 0.0%
H: 8.0%
C: 7.81%
meeting therapeutics presentation
Equillium Announces Presentation of Data Demonstrating Biological Importance of Multi-Cytokine Inhibitors EQ101 and EQ102 at the La Jolla Immunology Conference
Published: 2022-10-26 (Crawled : 13:00) - biospace.com/
EQ | $1.8 4.65% 4.44% 110K
|
Health Technology
|
| O: 0.0%
H: 1.81%
C: 0.0%
eq101 conference immunology presentation
Alterity Therapeutics Announces Presentation of MRI Data from the bioMUSE Natural History Study at the American Neurological Association Annual Meeting
Published: 2022-10-26 (Crawled : 12:00) - biospace.com/
ATHE | $2.33 9.39% 8.58% 170K
|
Health Technology
|
| O: 1.64%
H: 2.2%
C: -4.42%
meeting neurological therapeutics presentation study
TG Therapeutics Announces Presentation of Exploratory Analyses from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis Presented at the 2022 European Committee for Treatment and Research in Multiple Sclerosis
Published: 2022-10-26 (Crawled : 12:00) - globenewswire.com
TGTX | $13.99 -1.83% -1.86% 2.7M
|
Health Technology
|
| O: -0.93%
H: 11.07%
C: 3.75%
treatment trials research therapeutics presentation sclerosis multiple sclerosis
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.